| ABC | Aberrant Behavior Checklist; |
| ABC-2 | Aberrant Behavior Checklist second edition; |
| AFU | Active Fluorescent Units; |
| ASD | autism spectrum disorders; |
| ATECAutism | Treatment Evaluation Checklist; |
| CARS | Childhood Autism Rating Scale; |
| CFU | colony-forming units; |
| CNS | central nervous system; |
| CGI | Clinical Global Impression; |
| CPRS-R | Conners’ Parent Rating Scale—Revised; |
| FDA | Food and Drug Administration; |
| FMT | fecal microbiota transplantation; |
| GABA | gamma-aminobutyric acid; |
| GI | gastrointestinal; |
| GM | gut microbiota; |
| GOS | galactooligosaccharides; |
| GR | glucoraphanin; |
| ISAPP | International Scientific Association for Probiotics and Prebiotics; |
| IU | international unit; |
| KD | ketogenic diet; |
| LPS | lipopolysaccharide; |
| MGBA | microbiota–gut–brain axis; |
| MTT | microbiota transfer therapy; |
| OXT | oxytocin; |
| PEG | polyethylene glycol; |
| PICOS | population, intervention, comparison, outcome, study design; |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses; |
| PRIMSA-Scr | PRISMA Extension for Scoping Reviews; |
| PROSPERO | International Prospective Register of Systematic Reviews; |
| RBS-R | Repetitive Behavior Scale—Revised; |
| SCFA | short-chain fatty acids; |
| SHGM | Standardized Human Gut Microbiota; |
| SpCO | carboxyhemoglobin; |
| SRS | Social Responsiveness Scale; |
| TD | typically developing. |